GlassScriptPhysician profile
Michael R Nelson
NPI 1124188875
$2,993.99
in general payments reported to CMS, 2019-2025
8 companies · $67.51 in 2025
The $67.51 reported for 2025 was less than what a typical Clinical & Laboratory Immunology (Allergy & Immunology) provider received nationally (typical 2025 total: $1,390).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.95 · 2022: $452 · 2023: $2,394 · 2024: $34.76 · 2025: $67.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,275 · Food and Beverage: $164 · Education: $57.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,275.00 |
| Food and Beverage | $163.91 |
| Education | $57.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $2,336.64 | 2023 | Auvi-Q |
| Aimmune Therapeutics, INC. | $236.34 | 2022 | |
| Alk-Abello, INC | $157.83 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $113.46 | 2021-2025 | |
| Glaxosmithkline, LLC. | $57.00 | 2023 | Arexvy |
| Abbvie INC. | $34.76 | 2024 | |
| Blueprint Medicines Corporation | $33.80 | 2022 | |
| Genzyme Corporation | $24.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.